Indiatimes on MSN1h
Ozempic receives FDA nod for treating chronic kidney disease; experts explain how diabetes drug reduces CKD riskThe US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug ...
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...
Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease.
The accused drug smuggler is to be extradited to NSW after he was arrested on a yacht on Australia Day allegedly trying to ...
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...
A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...
The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback